Stockreport

Innate Pharma Reports Full Year 2023 Financial Results and Business Update

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF Positive final results of lacutamab TELLOMAK Phase 2 trial in Sézary syndrome presented at ASH Annual Meeting 2023; final data in mycosis fungoides to be shared at an up [Read more]